Archived from the original on 24 January 2010
Clinically, observational studies have linked specific microbiome unit reduced microbial diversity, depletion of butyrate-producing taxa, and an altered estrobolome to higher breast cancer risk or more aggressive phenotypes, and small interventional trials and pilot studies have explored probiotic supplementation (commonly Lactobacillus and Bifidobacterium strains) (176), showing encouraging signals such as improvement in systemic inflammatory markers, attenuation of gastrointestinal and mucosal toxicities during chemotherapy, mitigation of antibiotic-associated diarrhoea, modest improvements in metabolic parameters and bone health, and favourable changes in gut microbial composition
Available pathways include: Gastric Sleeve Surgery Reduces stomach capacity and influences hunger hormones to support significant weight loss
Unlocking Longevity with DSIP Epithalon Peptide Stack This blog highlights how the DSIP peptide enhances sleep quality, reduces stress, and supports neurotransmitter balance, while Epithalon promotes anti-aging by stimulating telomerase activity to protect cellular DNA